News Related to Broad Institute of MIT and Harvard

Related coverage linked through entity extraction aliases.

CAR-T Therapy Expands Beyond Cancer: Ireland Milestone, New Trials and Genetic Insights

Aug 08, 2026

CAR-T therapy reaches 150 patients in Ireland and expands into autoimmune trials for lupus and MS. Kyverna's miv-cel nears FDA approval for stiff person syndrome, and new research links gene variants to CAR-T outcomes.

CRISPR Market Projected to Grow 24.1% as Companies Hit Milestones, Launch New Technologies

Feb 24, 2026

The global CRISPR and prime editing market is forecast to grow at 24.1% CAGR through 2031, driven by therapeutic advances and regulatory progress. Scribe Therapeutics achieved a second milestone with Eli Lilly, while new RNA production and gene editing technologies accelerate research.